Pharmacology, Toxicology and Pharmaceutical Science
Clinical Study
100%
Metformin
100%
Preclinical Study
100%
Cardiovascular Disease
100%
Non Insulin Dependent Diabetes Mellitus
28%
Randomized Clinical Trial
14%
Antiinflammatory Activity
14%
Glucagon Like Peptide 1 Receptor Agonist
14%
Sodium Glucose Cotransporter 2 Inhibitor
14%
sodium glucose cotransporter-2 inhibitors
14%
Keyphrases
Cardiovascular Disease
100%
Metformin
100%
Type 2 Diabetes Mellitus (T2DM)
33%
Observational Data
16%
A1 Receptor
16%
Cardiovascular Outcomes
16%
Glycemic Control
16%
Metformin Use
16%
Randomized Clinical Trial
16%
Receptor Agonist
16%
Anti-inflammatory Effect
16%
Clinical Trial Data
16%
Cardiovascular Effects
16%
Metabolic Properties
16%
Glucagon-like
16%
Cardiovascular Outcome Trials
16%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
16%
Medicine and Dentistry
Glycon
100%
Cardiovascular Disease
100%
Clinical Study
100%
Maturity Onset Diabetes of the Young
28%
Cardiovascular System
28%
Randomized Clinical Trial
14%
Glycemic Control
14%
Cardiovascular Effect
14%
Antiinflammatory Activity
14%
Glucagon-Like Peptide-1 Agonist
14%
Sodium Glucose Cotransporter 2 Inhibitor
14%